Marlene Pickl

495 total citations
9 papers, 396 citations indexed

About

Marlene Pickl is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Marlene Pickl has authored 9 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Cancer Research. Recurrent topics in Marlene Pickl's work include HER2/EGFR in Cancer Research (4 papers), Breast Cancer Treatment Studies (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Marlene Pickl is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Breast Cancer Treatment Studies (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Marlene Pickl collaborates with scholars based in Switzerland, Germany and Austria. Marlene Pickl's co-authors include Carola H. Ries, Miro Venturi, Yung‐Jue Bang, Do‐Youn Oh, Tae-You Kim, José Baselga, S. Tjulandin, Seock‐Ah Im, Han‐Kwang Yang and Semiglazov Vf and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and European Journal of Cancer.

In The Last Decade

Marlene Pickl

9 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marlene Pickl Switzerland 6 241 172 130 71 62 9 396
Steffi Lehmann Switzerland 8 222 0.9× 155 0.9× 203 1.6× 149 2.1× 60 1.0× 14 555
Elodie Henriet United States 11 197 0.8× 110 0.6× 179 1.4× 150 2.1× 33 0.5× 13 511
Aaron E. Chiou United States 11 112 0.5× 121 0.7× 218 1.7× 42 0.6× 32 0.5× 15 410
Dorota E. Kuczek Denmark 4 316 1.3× 110 0.6× 119 0.9× 81 1.1× 18 0.3× 5 517
Annie Xiao United States 10 152 0.6× 63 0.4× 123 0.9× 35 0.5× 23 0.4× 19 385
Einav Zeevi United States 8 91 0.4× 178 1.0× 142 1.1× 38 0.5× 18 0.3× 33 465
Magdalena Zietarska Canada 6 185 0.8× 102 0.6× 208 1.6× 85 1.2× 11 0.2× 6 459
Elisa D’Arcangelo Canada 9 206 0.9× 199 1.2× 168 1.3× 76 1.1× 10 0.2× 14 446
Ralf Wiedemuth Germany 10 237 1.0× 57 0.3× 176 1.4× 44 0.6× 17 0.3× 15 487
Allison P. Drain United States 5 311 1.3× 135 0.8× 205 1.6× 198 2.8× 29 0.5× 5 624

Countries citing papers authored by Marlene Pickl

Since Specialization
Citations

This map shows the geographic impact of Marlene Pickl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlene Pickl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlene Pickl more than expected).

Fields of papers citing papers by Marlene Pickl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marlene Pickl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlene Pickl. The network helps show where Marlene Pickl may publish in the future.

Co-authorship network of co-authors of Marlene Pickl

This figure shows the co-authorship network connecting the top 25 collaborators of Marlene Pickl. A scholar is included among the top collaborators of Marlene Pickl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlene Pickl. Marlene Pickl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Pickl, Marlene, et al.. (2012). Predictive markers in early research and companion diagnostic developments in oncology. New Biotechnology. 29(6). 651–655. 9 indexed citations
2.
Scheltinga, Anton G.T. Terwisscha van, Marjolijn N. Lub–de Hooge, K. Abiraj, et al.. (2012). 315 ImmunoPET and Biodistribution with Human Epidermal Growth Factor Receptor 3 Targeting Radiolabeled Antibody 89Zr-GE-huMAb-HER3. European Journal of Cancer. 48. 96–97. 3 indexed citations
3.
Im, Seock‐Ah, Jin Won Kim, Jin-Soo Kim, et al.. (2011). Clinicopathologic Characteristics of Patients With Stage III/IV (M0) Advanced Gastric Cancer, According to HER2 Status Assessed by Immunohistochemistry and Fluorescence In Situ Hybridization. Diagnostic Molecular Pathology. 20(2). 94–100. 26 indexed citations
4.
Bianchini, Giampaolo, Aleix Prat, Marlene Pickl, et al.. (2011). Response to neoadjuvant trastuzumab and chemotherapy in ER+ and ER- HER2-positive breast cancers: Gene expression analysis.. Journal of Clinical Oncology. 29(15_suppl). 529–529. 16 indexed citations
5.
Pickl, Marlene, et al.. (2011). Comprehensive assessment of truncated HER2 in formalin-fixed paraffin embedded breast cancer tissue by chromogenic duplex immunohistochemistry.. Journal of Clinical Oncology. 29(15_suppl). e11059–e11059. 1 indexed citations
6.
Pardo, P. Gómez, Aleix Prat, Giampaolo Bianchini, et al.. (2011). PAM50 intrinsic subtyping and pathologic responses to neoadjuvant trastuzumab-based chemotherapy in HER2-positive breast cancer.. Journal of Clinical Oncology. 29(15_suppl). 554–554. 6 indexed citations
7.
Chung, Heesun, Yung‐Jue Bang, Jingyu Xu, et al.. (2009). 6511 Human epidermal growth factor receptor 2 (HER2) in gastric cancer (GC): results of the ToGA trial screening programme and recommendations for HER2 testing. European Journal of Cancer Supplements. 7(2). 364–364. 13 indexed citations
8.
Pickl, Marlene & Carola H. Ries. (2008). Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab. Oncogene. 28(3). 461–468. 319 indexed citations
9.
Pickl, Marlene, et al.. (2001). Oxyanion-Mediated Protein Stabilization: Differential Roles of Phosphate for Preventing Inactivation of Bacterial α-Glucan Phosphorylases. Biocatalysis and Biotransformation. 19(5-6). 379–398. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steffi Lehmann Breakdown of academic impact, for papers by Elodie Henriet Breakdown of academic impact, for papers by Aaron E. Chiou Breakdown of academic impact, for papers by Dorota E. Kuczek Breakdown of academic impact, for papers by Annie Xiao Breakdown of academic impact, for papers by Einav Zeevi Breakdown of academic impact, for papers by Magdalena Zietarska Breakdown of academic impact, for papers by Elisa D’Arcangelo Breakdown of academic impact, for papers by Ralf Wiedemuth Breakdown of academic impact, for papers by Allison P. Drain
Rankless by CCL
2026